Cognizant Trading Volume Plummets 45% to 455th Rank Amid Stock Price Decline
On July 11, 2025, CognizantCTSH-- (CTSH) experienced a significant decline in trading volume, with a total of 2.03 billion shares traded, marking a 44.96% decrease from the previous day. This drop placed Cognizant at the 455th position in terms of trading volume for the day. The stock price also saw a 1.79% decrease, marking the third consecutive day of decline, with a total drop of 6.63% over the past three days.
Cognizant has recently launched the Cognizant Agent Foundry platform, a comprehensive solution designed to help enterprises implement and scale autonomous AI agents. This platform features modular components that support adaptive operations, real-time decision-making, and personalized experiences, enabling continuous, agent-driven transformation.
In addition to the Agent Foundry platform, Cognizant has been actively involved in various strategic initiatives. The company has renewed its collaboration with Aker Solutions to drive IT transformation with an AI-first approach. This partnership aims to leverage AI technologies to enhance operational efficiency and innovation.
Cognizant has also expanded its presence in India with the announcement of a new campus in Visakhapatnam. This expansion is part of the company's broader strategy to strengthen its operations and talent pool in the region. Additionally, Cognizant has deepened its partnership with SalesforceCRM--, introducing new offerings for Agentforce to enhance customer service and support.
Furthermore, Cognizant has been recognized as a leader in the Everest GroupEG-- Intelligent Process Automation Solutions PEAK Matrix® Assessment 2025. This recognition highlights the company's expertise in delivering innovative automation solutions that drive operational excellence and business growth.

Hunt down the stocks with explosive trading volume.
Latest Articles
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments
No comments yet